Electronic eye trial brings hope for blindness cure
Patients suffering from retinitis pigmentosa (RP) have been given renewed hoped for a cure today after trials of an electronic eye implant were a great success.
According to scientists, for the patients that received the electronic microchips, useful vision was being restored only weeks after they were fitted.
The technology was developed by Retina Implant AG, a leading developer of subretinal implants and the trial took place in the UK.
The scientists involved in the experiment said it had “exceeded expectations.”
To read the latest edition of Healthcare Global, click here
- Aspirin is as effective as warfarin for heart patients
- Memory problems reduce with exercise and computer games
- World’s first degree in plastic surgery launches in UK
In mid-April two patients with RP were fitted with the microchips and immediately afterwards they were able to detect light.
More testing revealed that they were also able to identify white objects when they were set against a dark background.
Their progress will continue to be monitored over the coming months and 10 more RP sufferers are also going to be fitted with the electronic microchips as part of the trial.
It is being led by two British eye experts.
Tim Jackson is a consultant retinal surgeon at King's College Hospital in London while Robert MacLaren is a professor of Ophthalmology at the University of Oxford and a consultant retinal surgeon at the Oxford Eye Hospital.
Commenting on the trial and the effectiveness of the microchips, they said: "The visual results of these patients exceeded our expectations.
“This technology represents a genuinely exciting development and is an import step forward in our attempts to offer people with RP a better quality of life.”
Meanwhile, David Head from the charity RP Fighting Blindness, added: “The completion of the first two implants in the UK is very significant and brings hope to people who have lost their sight as a result of RP.”
Testing for this type of technology - subretinal implants – has been taking place for six years in the UK and Europe and following this latest success there are plans to seek commercial approval for the implants.
The Healthcare Global magazine is now available on the iPad. Click here to download it.
Featured Articles
NTT and medical technology company Olympus put on a demonstration, showing the IOWN APN's low-latency capability, for the first cloud endoscopy system
Richter BioLogics GmbH & Co KG's a new biopharmaceutical GMP facility in Germany will boost production capabilities and local employment
A pilot study from GE Healthcare has shown the value of Portrait Mobile Continuous Monitoring Solution, a leap in post-surgical monitoring efficiency